Search - tctmd.com

Displaying 101 - 120 of 150

Sort: Relevancy | Date

Presentation TCT 2018

PERT: The Time is Now

Presenter: Kenneth Rosenfield, Victor F. Tapson

September 22, 2018

Presentation TCT 2018

Catheter Directed Therapy for Acute PE

Presenter: Kenneth Rosenfield, Victor F. Tapson, Gregory Piazza

September 22, 2018

Presentation TCT 2018

Systemic Therapy for Acute PE

Presenter: Kenneth Rosenfield, Victor F. Tapson, Jay S. Giri

September 22, 2018

Presentation TCT 2018

Incidence and Diagnosis

Presenter: Kenneth Rosenfield, Victor F. Tapson

September 22, 2018

Presentation TCT 2018

Aria: A Device-Based Approach to RV Failure and Pulmonary Compliance

Presenter: Ori Ben-Yehuda, Jay S. Giri, Irene M. Lang

September 22, 2018

Presentation TCT 2018

Implantable Devices for Pulmonary Hypertension

Presenter: Ori Ben-Yehuda, Jay S. Giri, William T. Abraham

September 22, 2018

Presentation TCT 2018

Pulmonary Artery Denervation III: Ultrasound-Based Therapy and Results

Presenter: Ori Ben-Yehuda, Jay S. Giri

September 22, 2018

Presentation TCT 2018

Pulmonary Artery Denervation II: RF Ablation Device and Latest Results

Presenter: Ori Ben-Yehuda, Jay S. Giri, Shao-Liang Chen

September 22, 2018

Presentation TCT 2018

Pulmonary Artery Denervation I: Concepts and Pre-Clinical Data

Presenter: Ori Ben-Yehuda, Jay S. Giri, Alex M. K. Rothman

September 22, 2018

Presentation TCT 2018

Overview of Group I Pulmonary Hypertension

Presenter: Ori Ben-Yehuda, Jay S. Giri

September 22, 2018

Presentation TCT 2018

A Vascular Compliance Enhancing Device for Treatment of Pulmonary Arterial Hypertension: Aria CV

Presenter: Louis A. Cannon, Juan F. Granada, John Scandurra

September 22, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News ESC 2018

Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD

Todd Neale

August 31, 2018

News Conference News ESC 2018

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Michael O'Riordan

August 26, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

Atrial Fibrillation Risk Increased in People With Asthma

Michael O'Riordan

July 13, 2018

News Daily News

NSAIDs Account for Large Part of Osteoarthritis-CVD Link, Study Suggests

Todd Neale

June 21, 2018

News Industry News

Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

May 08, 2018

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

Presentation ECHO 2018

Pulmonary Hypertension and the Role of Echocardiography

Presenter: Linda D. Gillam

April 19, 2018

Advertisement

PERT: The Time is Now

Catheter Directed Therapy for Acute PE

Systemic Therapy for Acute PE

Incidence and Diagnosis

Aria: A Device-Based Approach to RV Failure and Pulmonary Compliance

Implantable Devices for Pulmonary Hypertension

Pulmonary Artery Denervation III: Ultrasound-Based Therapy and Results

Pulmonary Artery Denervation II: RF Ablation Device and Latest Results

Pulmonary Artery Denervation I: Concepts and Pre-Clinical Data

Overview of Group I Pulmonary Hypertension

A Vascular Compliance Enhancing Device for Treatment of Pulmonary Arterial Hypertension: Aria CV

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Atrial Fibrillation Risk Increased in People With Asthma

NSAIDs Account for Large Part of Osteoarthritis-CVD Link, Study Suggests

Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Pulmonary Hypertension and the Role of Echocardiography

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content